Polymorphisms | Â | Total | Male | Female | |||
---|---|---|---|---|---|---|---|
 | Genotypes | Control n (%) | OSAS group n (%) | Control n (%) | OSAS group n (%) | Control n (%) | OSAS group n (%) |
rs5417 | AA | 28 (18.4) | 53 (13.1) | 22 (22.0) | 46 (14.1) | 6 (11.5) | 7 (9.0) |
AC | 85 (55.9) | 200 (29.4) | 56 (56.0) | 151 (46.2) | 29 (55.8) | 49 (62.8) | |
CC | 39 (25.7) | 152 (37.5) | 22 (22.0) | 130 (39.8) | 17 (32.7) | 22 (28.2) | |
 |  | Χ2 = 7.630, P = 0.022 |  | Χ2 = 11.332,P = 0.003 | Χ2 = 0.673, P = 0.714 | ||
A | 141 (46.4) | 306 (53.6) | 100 (50.0) | 243 (37.2) | 41 (39.4) | 63 (40.4) | |
C | 163 (53.6) | 504 (62.2) | 100 (50.0) | 411 (62.8) | 63 (60.6) | 93 (59.6) | |
 |  |  | Χ2 = 6.811, P = 0.009 |  | Χ2 = 10.514, P = 0.001 | Χ2 = 0.024, P = 0.877 | |
 | CC | 73 (48.0) | 209 (51.4) | 54 (52.9) | 170 (51.7) | 19 (38.0) | 39 (50.0) |
 | CT | 67 (44.1) | 154 (37.8) | 40 (39.2) | 120 (36.5) | 27 (54.0) | 34 (43.6) |
 | TT | 12 (7.9) | 44 (10.8) | 8 (7.8) | 39 (11.9) | 4 (8.0) | 5 (6.4) |
rs5415 |  |  | Χ2 = 2.272, P = 0.321 |  | Χ2 = 1.330,P = 0.514 | Χ2 = 0.668, P = 0.716 | |
 | C | 213 (70.1) | 572 (70.3) | 148 (72.5) | 460 (69.9) | 65 (65.0) | 112 (71.8) |
 | T | 91 (29.9) | 242 (29.7) | 56 (27.5) | 198 (30.1) | 35 (35.0) | 44 (28.2) |
 |  |  | Χ2 = 0.004, P = 0.947 |  | Χ2 = 0.522,P = 0.470 | Χ2 = 1.319, P = 0.251 | |
 | CC | 66 (43.7) | 187 (46.4) | 44 (44.4) | 157 (47.9) | 22 (42.3) | 30 (40.0) |
 | CT | 71 (47.0) | 169 (41.9) | 48 (48.5) | 128 (39.0) | 23 (44.2) | 41 (54.7) |
 | TT | 14 (9.3) | 47 (11.7) | 7 (7.1) | 43 (13.1) | 7 (13.5) | 4 (5.3) |
rs5435 |  |  | Χ2 = 1.400, P = 0.497 |  | Χ2 = 4.209, P = 0.122 | Χ2 = 3.046 P = 0.218 | |
 | C | 203 (67.2) | 543 (67.4) | 136 (68.7) | 542 (71.7) | 67 (64.4) | 101 (67.3) |
 | T | 99 (32.8) | 263 (32.6) | 62 (31.1) | 214 (28.3) | 37 (35.6) | 49 (32.7) |
 |  |  | Χ2 = 0.002, P = 0.962 |  | Χ2 = 4.690, P = 0.406 | Χ2 = 0.232, P = 0.630 |